Long-acting formulation composition of relugolix

TW202637174APending Publication Date: 2026-09-16QILU PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145538
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-18
Filing Date
2025-11-21
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076479_001
    Figure TWG2TA001076479_001
  • Figure TWG2TA001076479_002
    Figure TWG2TA001076479_002
  • Figure TWG2TA001076479_003
    Figure TWG2TA001076479_003
Patent Text Reader

Abstract

The present invention discloses a long-acting formulation composition of Relugolix, its preparation method, and application. This composition comprises an active pharmaceutical ingredient and at least one suspending agent. The long-acting formulation composition of Relugolix of the present invention has excellent sustained-release properties, extending the dosing interval from once daily to once every
Need to check novelty before this filing date? Find Prior Art